文献速递肾移植

肾移植病理期间外周血转录组谱的生物学通路及其与活检信号和细胞来源的比较

Biological pathways and comparison with biopsy signals and cellular origin of peripheral blood transcriptomic profiles during kidney allograft pathology.
PubMed 文献 · Kidney Int · 2022-05-05

研究分析四个欧洲移植中心384份肾移植活检时采集的外周血样本的RNA测序,比较136份排斥与248份无排斥样本的差异表达基因,显示糖皮质激素受体和核苷酸寡聚化结构域样受体信号通路上调。抗体介导排斥(ABMR)富集通路具强免疫特异性,T细胞介导排斥富集通路免疫相关性较弱,多瘤病毒感染见线粒体功能障碍和干扰素信号通路上调。整合224份活检转录组及7份活检单细胞RNA测序,ABMR中持续过表达基因多由移植物浸润白细胞表达,并在外周血免疫细胞亚型中过表达,且在独立队列中确认。

要点

  • 排斥时外周血可见糖皮质激素受体和核苷酸寡聚化结构域样受体信号通路上调。
  • ABMR富集通路具强免疫特异性,T细胞介导排斥富集通路免疫相关性较弱。
  • 多瘤病毒感染见线粒体功能障碍和干扰素信号通路上调。

核心结论

  • 肾移植病理时外周血白细胞存在免疫激活通路,尽管使用当前强效免疫抑制剂,为未来治疗干预提供框架。

研究设计与样本

  • 分析四个欧洲移植中心384份肾移植活检时采集的外周血样本,按表型选择,行RNA测序。
  • 整合224份肾移植活检转录组及7份肾移植活检单细胞RNA测序分析。
  • 在血液和活检独立队列中确认ABMR相关基因过表达。

主要发现

  • 外周血136份排斥与248份无排斥样本差异表达基因显示糖皮质激素受体和核苷酸寡聚化结构域样受体信号通路上调。
  • ABMR富集通路具强免疫特异性,T细胞介导排斥富集通路免疫相关性较弱。
  • 多瘤病毒感染见线粒体功能障碍和干扰素信号通路上调。
  • 血液与活检转录组整合显示每个表型在血液和活检中持续上调基因。
  • 7份活检单细胞RNA测序显示ABMR持续过表达基因多由移植物浸润白细胞表达,外周血单细胞RNA测序显示这些基因在ABMR免疫细胞亚型中过表达。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Kidney transplant injury processes are associated with molecular changes in kidney tissue, primarily related to immune cell activation and infiltration. How these processes are reflected in the circulating immune cells, whose activation is targeted by strong immunosuppressants, is poorly understood. To study this, we analyzed the molecular alterations in 384 peripheral blood samples from four European transplant centers, taken at the time of a kidney allograft biopsy, selected for their phenotype, using RNA-sequencing. In peripheral blood, differentially expressed genes in 136 rejection and 248 no rejection samples demonstrated upregulation of glucocorticoid receptor and nucleotide oligomerization domain-like receptor signaling pathways. Pathways enriched in antibody-mediated rejection (ABMR) were strongly immune-specific, whereas pathways enriched in T cell-mediated rejection were less immune related. In polyomavirus infection, upregulation of mitochondrial dysfunction and interferon signaling pathways was seen. Next, we integrated the blood results with transcriptomics of 224 kidney allograft biopsies which showed consistently upregulated genes per phenotype in both blood and biopsy. In single-cell RNASeq (scRNASeq) analysis of seven kidney allograft biopsies, the consistently overexpressed genes in ABMR were mostly expressed by infiltrating leukocytes in the allograft. Similarly, in peripheral blood scRNASeq analysis, these genes were overexpressed in ABMR in immune cell subtypes. Furthermore, overexpression of these genes in ABMR was confirmed in independent cohorts in blood and biopsy. Thus, our results highlight the immune activation pathways in peripheral blood leukocytes at the time of kidney allograft pathology, despite the use of current strong immunosuppressants, and provide a framework for future therapeutic interventions.

来源:Kidney Int,查看原文。版权归原作者所有。

引用

  1. Van Loon E, Lamarthée B, de Loor H, et al. Biological pathways and comparison with biopsy signals and cellular origin of peripheral blood transcriptomic profiles during kidney allograft pathology. Kidney Int. 2022. PMID: 35526671. doi:10.1016/j.kint.2022.03.026

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。